1. IL-6: The Link Between Inflammation, Immunity and Breast Cancer
   Juan Chen et al, 2022, Frontiers in Oncology CrossRef
2. OLFML2A is necessary for anti-triple negative breast cancer effect of selective activator protein‐1 inhibitor T-5224
   Qian Zhao et al, 2021, Translational Oncology CrossRef
3. Comparative genomic hybridisation and transcriptome microarray analysis in triple negative breast cancer: An INDIAN study.
   Hemangini Vora et al, 2023, Advances in Cancer Biology - Metastasis CrossRef
4. Phenotypic and microRNA transcriptomic profiling of the MDA-MB-231 spheroid-enriched CSCs with comparison of MCF-7 microRNA profiling dataset
   Lily Boo et al, 2017, PeerJ CrossRef
5. Sequencing for germline mutations in Swedish breast cancer families reveals novel breast cancer risk genes
   Hafdis T. Helgadottir et al, 2021, Scientific Reports CrossRef
6. Bioinformatics analysis of gene expression profiles to identify causal genes in luminal B2 breast cancer
   Jinguang Wang et al, 2017, Oncology Letters CrossRef
7. Mitochondria-related core genes and TF-miRNA-hub mrDEGs network in breast cancer
   Li-rong Yan et al, 2021, Bioscience Reports CrossRef
8. A Model-free Variable Screening Method Based on Leverage Score
   Wenxuan Zhong et al, 2023, Journal of the American Statistical Association CrossRef
9. Robust Identification of Differential Gene Expression Patterns from Multiple Transcriptomics Datasets for Early Diagnosis, Prognosis, and Therapies for Breast Cancer
   Khanis Tuly et al, 2023, Medicina CrossRef
10. Integrated bioinformatics and statistical approaches to explore molecular biomarkers for breast cancer diagnosis, prognosis and therapies
    Md. Shahin Alam et al, 2022, PLOS ONE CrossRef
11. LSM3, NDUFB3, and PTGS2 may be potential biomarkers for BRCA1-mutation positive breast cancer
    Kang Hu et al, 2020, Revista Romana de Medicina de Laborator CrossRef